Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1956 1
1957 1
1958 2
1960 1
1967 3
1970 2
1971 1
1972 2
1973 3
1974 2
1975 1
1977 1
1978 2
1979 2
1980 2
1981 3
1982 3
1983 2
1984 2
1985 1
1986 2
1987 1
1988 1
1989 1
1990 1
1991 2
1992 2
1993 1
1995 3
1996 1
1997 1
1998 1
1999 2
2000 3
2001 1
2002 1
2003 1
2004 2
2005 7
2007 4
2008 5
2009 1
2010 3
2011 2
2012 7
2013 2
2014 4
2015 3
2016 3
2017 7
2018 6
2019 9
2020 10
2021 8
2022 9
2023 5
2024 15
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Results by year

Filters applied: . Clear all
Page 1
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB; UNITY Study Group. Moise KJ Jr, et al. N Engl J Med. 2024 Aug 8;391(6):526-537. doi: 10.1056/NEJMoa2314466. N Engl J Med. 2024. PMID: 39115062 Clinical Trial.
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L; NeoVitaA trial investigators. Meyer S, et al. Lancet Respir Med. 2024 Jul;12(7):544-555. doi: 10.1016/S2213-2600(24)00073-0. Epub 2024 Apr 18. Lancet Respir Med. 2024. PMID: 38643780 Clinical Trial.
Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus.
Mustafa HJ, Sambatur EV, Shamshirsaz AA, Johnson S, Moise KJ Jr, Baschat AA, Joanne Verweij EJT, Javinani A, Kilby MD, Lopriore E, Rose R, Devlieger R, Snowise S, Sachs UJ, Khalil A; HDFN Delphi Working Group. Mustafa HJ, et al. Am J Obstet Gynecol. 2025 Mar;232(3):280-300. doi: 10.1016/j.ajog.2024.11.003. Epub 2024 Nov 14. Am J Obstet Gynecol. 2025. PMID: 39547350
Preventing employee burnout.
Jackson SE, Schuler RS. Jackson SE, et al. Among authors: schuler rs. Personnel. 1983 Mar-Apr;60(2):58-68. Personnel. 1983. PMID: 10261205
Parents are parenting and not visiting.
Schuler R, Mihatsch WA. Schuler R, et al. Acta Paediatr. 2024 Jun;113(6):1464. doi: 10.1111/apa.17202. Epub 2024 Mar 16. Acta Paediatr. 2024. PMID: 38491823 No abstract available.
Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn.
de Winter DP, Verweij EJTJ, Debeer A, Devlieger R, Lewi L, Verbeeck S, Maurice P, Jouannic JM, Guillemin MG, Mailloux A, Pessoa Dos Santos MC, Amaral de Moura Sá Pacheco C, Lopes Moreira ME, Martins de Vasconcelos Vaena M, Bohlin K, Tiblad E, Thorup E, Petersen OB, Sanchez-Holgado M, Viejo Llorente A, Poljak B, Khalil A, Le Duc K, Ghesquiere L, Lozar Krivec J, Soltirovska-Šalamon A, Dame C, Blank JD, Hohnecker A, Saxonhouse M, Connors NK, Geipel A, Rath J, Prasad S, van Wyk L, Geerts L, Schuler R, Thon N, Leibovitch L, Cohen S, Canul-Euan AA, Kelly E, Raghuram K, Cavigioli F, Colombo SFG, Elanjikal Z, Brayley J, Pfurtscheller D, Pichler G, Alcázar Grisi ÁG, Chávez Navarro EJJ, Pereira-Nunes J, Soares H, Zhou M, Garcia Borau MJ, Moliner Calderón E, Galletti MF, Mariani GL, Mackin D, Malone F, Lampland A, Tse WT, Castleman J, van der Bom JG, de Haas M, Lopriore E; Worldwide Collaboration for Hemolytic Disease of the Fetus and Newborn (DIONYSUS) Investigators. de Winter DP, et al. Among authors: schuler r. JAMA Netw Open. 2025 Jan 2;8(1):e2454330. doi: 10.1001/jamanetworkopen.2024.54330. JAMA Netw Open. 2025. PMID: 39792381 Free PMC article.
FaceBase: A Community-Driven Hub for Data-Intensive Research.
Schuler RE, Bugacov A, Hacia JG, Ho TV, Iwata J, Pearlman L, Samuels BD, Williams C, Zhao Z, Kesselman C, Chai Y. Schuler RE, et al. J Dent Res. 2022 Oct;101(11):1289-1298. doi: 10.1177/00220345221107905. Epub 2022 Jul 31. J Dent Res. 2022. PMID: 35912790 Free PMC article. Review.
Deciphering DST-associated disorders: biallelic variants affecting DST-b cause a congenital myopathy.
Jacob M, Kölbel H, Harrer P, Kopajtich R, Munot P, Achleitner MT, Badmann S, Brugger M, Brunet T, Bonne G, Codina M, Ebner L, Eshraghi P, Eyring K, Farhat AS, Feichtinger RG, Graf E, Marcé-Grau A, Hahn A, Houlden H, Karimiani EG, Manel V, Mayerhanser K, Nectoux J, Nelson I, Phadke R, Prokisch H, Sadeghian S, Saparov A, Schänzer A, Schara-Schmidt U, Schmidt J, Schuler R, Sewry C, Shariati G, Slanz S, Smirnov D, Sukenik-Halevy R, Tajsharghi H, Toosi MB, Trujillano L, Weis J, Wilson LC, Ben Yaou R, Zamani M, Zech M, Zschüntzsch J, Kornak U, Goméz-Andrés D, Maroofian R, Winkelmann J, Roos A, Distelmaier F, Mayr JA, Wagner M. Jacob M, et al. Among authors: schuler r. Brain. 2025 Jun 11:awaf227. doi: 10.1093/brain/awaf227. Online ahead of print. Brain. 2025. PMID: 40497796
Cognitive function in SMA patients with 2 or 3 SMN2 copies treated with SMN-modifying or gene addition therapy during the first year of life.
Steffens P, Weiss D, Perez A, Appel M, Weber P, Weiss C, Stoltenburg C, Ehinger U, von der Hagen M, Schallner J, Claussen B, Lode I, Hahn A, Schuler R, Ruß L, Ziegler A, Denecke J, Johannsen J. Steffens P, et al. Among authors: schuler r. Eur J Paediatr Neurol. 2024 Jul;51:17-23. doi: 10.1016/j.ejpn.2024.05.002. Epub 2024 May 8. Eur J Paediatr Neurol. 2024. PMID: 38772209 Free article.
173 results